Numa

Overview

Numa is a digital platform for decentralized clinical trials centered on collecting and analyzing motor biomarker data. Originating as a refined evolution of an earlier engagement with InDVI, the initiative serves as a core proof of capability for Teqqed, demonstrating our execution standard in architecting high-density scientific UI and complex clinical workflows without sacrificing clarity.

Challenge

Clinical trial interfaces often suffer from dense, fragmented data displays that alienate researchers and lower participant protocol compliance. The challenge was twofold: structuring high-frequency motor biomarker metrics into an instantly legible dashboard hierarchy, while establishing an uncompromising editorial visual identity that builds immediate credibility with pharmaceutical stakeholders and scientific investigators.

Approach

We approached the system through structured information architecture and precise visual calibration:

• High-Precision Data Hierarchy: Organized raw biomarker streams into scannable telemetry modules and clean comparative states, cutting cognitive load for clinical researchers.
• Editorial & Scientific Brand Language: Paired rigorous typography and tight grid structures with an understated palette, deliberately moving away from dated medical software aesthetics toward high-trust authority.
• Multi-Surface Deliverables: Executed a high-converting Framer landing page tailored for waitlist acquisition, supported by technical LinkedIn data-visualization assets and comprehensive brand guidelines.

Solution

Delivered a cohesive, end-to-end brand and digital presence that repositions decentralized motor trial software as modern, precise, and research-grade. The system successfully validates Teqqed’s capability to handle enterprise-grade scientific tooling while delivering an immediate platform for waitlist growth and stakeholder engagement.